Cargando…
Putative malignant hyperthermia mutation Ca(V)1.1-R174W is insufficient to trigger a fulminant response to halothane or confer heat stress intolerance
Malignant hyperthermia susceptibility (MHS) is an autosomal dominant pharmacogenetic disorder that manifests as a hypermetabolic state when carriers are exposed to halogenated volatile anesthetics or depolarizing muscle relaxants. In animals, heat stress intolerance is also observed. MHS is linked t...
Autores principales: | Feng, Wei, Lopez, Jose R., Antrobus, Shane, Zheng, Jing, Uryash, Arkady, Dong, Yao, Beqollari, Donald, Bannister, Roger A., Hopkins, Philip M., Beam, Kurt G., Allen, Paul D., Pessah, Isaac.N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Biochemistry and Molecular Biology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10413282/ https://www.ncbi.nlm.nih.gov/pubmed/37392848 http://dx.doi.org/10.1016/j.jbc.2023.104992 |
Ejemplares similares
-
Update of the quality assurance (QA) results of halothane and caffeine analysis of all current participating malignant hyperthermia units
por: Fisher, Nickla, et al.
Publicado: (2014) -
A malignant hyperthermia–inducing mutation in RYR1 (R163C): consequent alterations in the functional properties of DHPR channels
por: Bannister, Roger A., et al.
Publicado: (2010) -
Voltage modulates halothane-triggered Ca(2+) release in malignant hyperthermia-susceptible muscle
por: Zullo, Alberto, et al.
Publicado: (2018) -
A malignant hyperthermia–inducing mutation in RYR1 (R163C): alterations in Ca(2+) entry, release, and retrograde signaling to the DHPR
por: Estève, Eric, et al.
Publicado: (2010) -
Halothane-induced hepatitis: A forgotten issue in developing countries: Halothane-induced hepatitis
por: Habibollahi, Peiman, et al.
Publicado: (2011)